收藏切换
Mechanistic studies of the beneficial effects of Anshen Dingzhi prescription for PTSD treatment: roles of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway
收藏切换
PDF
Daokang Chen1, Jiamin Hu1, Shaojie Yang1, Pan Xie1, Manman Ji1, Zhengrong Zhang1, Michel Baudry2, Sheng Zhang1, *, Guoqi Zhu1, *
Acupuncture and Herbal Medicine | 2025, 5(3) : 316 - 327
Less
收藏切换
Acupuncture and Herbal Medicine | 2025, 5(3): 316-327
• Original Articles •
Mechanistic studies of the beneficial effects of Anshen Dingzhi prescription for PTSD treatment: roles of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway
Full
Daokang Chen1, Jiamin Hu1, Shaojie Yang1, Pan Xie1, Manman Ji1, Zhengrong Zhang1, Michel Baudry2, Sheng Zhang1, *, Guoqi Zhu1, *
Affiliations
  • 1Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, and Key Laboratory of Molecular Biology (Brain diseases), Anhui University of Chinese Medicine, Hefei, China
  • 2CDM, Western University of Health Sciences, Pomona, CA
About Author:

Daokang Chen and Jiamin Hu contributed equally to this work.

Published: 2025-09-25 doi: 10.1097/HM9.0000000000000164
Outline
收藏切换
Objective:

Anshen Dingzhi prescription (ADP) is an effective remedy for treating post-traumatic stress disorder (PTSD); however, the mechanism underlying its beneficial effects is unclear. This study explores the roles of the neuroinflammation regulated by the FKBP prolyl isomerase 5 (FKBP5)-IκB kinase alpha (IKKα)-nuclear factor kappa-B (NF-κB)-NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) signaling pathway in PTSD.

Methods:

The primary components of ADP, including ginsenosides Rg1 and Rb1, were quantified using ultra-performance liquid chromatography. Twelve C57BL/6 mice were allocated to control (D0) and experimental groups on days one, seven, and 14 of single prolonged stress (SPS). Eighteen C57BL/6 mice were allocated to control, SPS, and MCC950, an NLRP3 inhibitor (5 mg/kg) groups. Finally, 24 C57BL/6 mice were allocated to control, SPS, paroxetine hydrochloride (PRX), or ADP (18.4 and 36.8 mg/kg) groups. Mice were administered MCC950, PRX, or ADP for 14 days. The open field test and elevated plus maze were used to evaluate anxiety-like behaviors, whereas fear memory extinction was evaluated using the fear memory test. Western blotting was employed to evaluate the expression levels of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway, tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β. The expression of FKBP5 and NLRP3 was further confirmed by immunofluorescence staining.

Results:

The amounts of ginsenosides Rg1 and Rb1 in ADP were (96.85 ± 1.14) and (9.04 ± 0.22) μg/g, respectively. Compared with the D0 group, the levels of the inflammatory cytokine proteins, TNF-α, IL-6, and IL-1β were elevated 1.33- to 1.51-fold and those of FKBP5-IKKα-NF-κB-NLRP3 signaling pathway were increased 1.16- to 1.41-fold in the hippocampus of the D14 group (P < 0.05); the fluorescence intensity of FKBP5 and NLRP3 was also markedly increased (1.33-1.79-fold) in the hippocampus of the D14 group (P < 0.5). Notably, injection of MCC950 (5 mg/kg) reduced the levels of FKBP5-IKKα-NF-κB-NLRP3 (0.80-0.88-fold) and inflammatory cytokines (0.74-0.83-fold), thereby improving the PTSD-like behaviors induced by SPS (P < 0.05). In addition, ADP (36.8 g/kg) significantly improved PTSD-like behaviors and reduced levels of hippocampal inflammatory cytokines (0.70-0.79-fold) and FKBP5-IKKα-NF-κB-NLRP3 (0.50-0.79-fold) (P < 0.05) in SPS mice.

Conclusion:

The results suggest a potential therapeutic benefit of ADP in PTSD due to the inhibition of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway.

Anshen Dingzhi prescription  /  FKBP5-IKKα-NF-κB-NLRP3 signaling pathway  /  Neuroinflammation  /  Post-traumatic stress disorder
Daokang Chen, Jiamin Hu, Shaojie Yang, Pan Xie, Manman Ji, Zhengrong Zhang, Michel Baudry, Sheng Zhang, Guoqi Zhu. Mechanistic studies of the beneficial effects of Anshen Dingzhi prescription for PTSD treatment: roles of the FKBP5-IKKα-NF-κB-NLRP3 signaling pathway[J]. Acupuncture and Herbal Medicine, 2025 , 5 (3) : 316 -327 . DOI: 10.1097/HM9.0000000000000164
  • National Natural Science Foundation of China(82404995; 82404890)
  • Research Funds of Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM(2023CXMMTCM013)
  • Scientific Research Program of Anhui Provincial Department of Education(2024AH051036; 2024AH040137; 2024AH051044)
  • Excellent Funding for Academic and Scientific Research Activities for Academic and Technological Leaders in Anhui Province(2022D317)
  • Key Research and Development Plan of Anhui Province(202104j07020004)
  • Anhui University of Chinese Medicine Talent Support Program(DT2300000173)
Year 2025 volume 5 Issue 3
PDF
3
1
Cite this Article
BibTeX
Article Info
doi: 10.1097/HM9.0000000000000164
  • Receive Date:2024-07-28
  • Online Date:2026-11-04
  • Published:2025-09-25
Article Data
Affiliations
History
  • Received:2024-07-28
  • Accepted:2025-06-19
Funding
National Natural Science Foundation of China(82404995; 82404890)
Research Funds of Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM(2023CXMMTCM013)
Scientific Research Program of Anhui Provincial Department of Education(2024AH051036; 2024AH040137; 2024AH051044)
Excellent Funding for Academic and Scientific Research Activities for Academic and Technological Leaders in Anhui Province(2022D317)
Key Research and Development Plan of Anhui Province(202104j07020004)
Anhui University of Chinese Medicine Talent Support Program(DT2300000173)
Affiliations
    1Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, and Key Laboratory of Molecular Biology (Brain diseases), Anhui University of Chinese Medicine, Hefei, China
    2CDM, Western University of Health Sciences, Pomona, CA

Corresponding:

* Sheng Zhang, E-mail: ;
Guoqi Zhu, E-mail: .
References
Share
https://castjournals.cast.org.cn/joweb/ahm/EN/10.1097/HM9.0000000000000164
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT